ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
k141_27358_4 # 2127 # 5237 # -1 # ID=25_4;partial=00;start_type=ATG;rbs_motif=AAA;rbs_spacer=11bp;gc_cont=0.497	k141_27358_4	2127	5237	-	Strict	750	769.229	adeF	42.65	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAAGTAAGTTTCTTTATAGACCGCCCGGTATTCTCGGCGGTGATATCGATTGTGATTGTAATTGTCGGTATCATTGGCCTGACCATGCTGCCGGTAGACCAATATCCGCAGATAACGCCTCCCGTAGTGAAAATCAGTGCTTCCTATCCGGGAGCCAGTGCATTGACTGTTTCGCAGGCGGTGGCAACCCCTATCGAGCAAGAGATAAACGGTACTCCCGGTATGCTGTACATGGAGTCCAACAGTTCTAATTCCGGAGGATTTTCAGCTACGGTCACTTTCGACGTGTCTGCCGACCCGGATTTGGCTGCCGTAGAAATACAGAACCGTGTGAAACTGGCGGAGAGCCGTTTGCCAGCCGAAGTGATTCAGAACGGTATTTCTGTGGAAAAGCAGGCTCCCAGCCAATTGATGACTATCTGTCTGACTTCCAGTGACCCGAAGTTCGACGAAATTTATTTGAGTAACTTTGCTACTATCAATGTACTCGACTTGTTGCGCCGTATCCCCGGTGTGGGACGTGTTTCCAACATCGGTAGCCGCTACTATGCCATGCAGATATGGGCGTTGCCCGACAAACTTGCCAACTTCGGACTGACGGTGCAGGATTTGCAGAATGCCCTGAAGGACCAGAACCGTGAGTCTGCTGCGGGTGTTTTGGGACAACAGCCGGTGAAGGGACTCGACATTACTATCCCTATCACTACCCAGGGACGTTTAAGTTCGGCAAAGCAGTTTGAGGACATTGTGGTCCGTGCCAATGCCAACGGTTCCATTATCCGTCTGCGCGATGTGGCGCGTGTTTCATTGGAAGCATCTTCATATAGCACAGAGAGTGGCATCAACGGTGAGAATGCTGCCGTTCTCGGTATCTATATGCTTCCCGGGGCCAATGCAATGGAAGTTGCAAAGAGCGTAAAGGCTGCTATGGAGGAAATCAGTGCAAATTTCCCTGAGGGGATGAGTTATGAGATTCCCTTCGACATGACGACTTATATTTCCGAATCCATTCACGAAGTGTACAAGACGTTGTTCGAAGCGCTGATTCTGGTGGTGCTGGTTGTATTTCTATCCTTGCAAAGTTGGCGTGCGACGGTGATACCGATTGTTGCGGTACCTATTTCCCTGATTGGTACCTTCGGTTTCATGCTTATTTTCGGTTTCTCTCTGAACATACTGACTTTGCTTGGATTGATTCTCGCCATCGGTATTGTGGTGGATGATGCCATTGTGGTGGTGGAGAATGTAGAACATCTTATGGAGACGGAGAAATTGAGCCCGTATGAAGCTACCAAAAGGGCGATGAACGGATTGGCAAGTGCCTTGATTGCCACATCGTTGGTGCTCTGTGCCGTGTTTGTGCCGGTAAGTTTCTTGAGCGGAATCACCGGACAGTTATACCGTCAGTTTACCATTACTATCGCCGTTTCCGTATTGCTTTCTACGGTAGTGGCCCTGACGCTTAGTCCCGTCATGTGTTCGCTCATATTGAAGCCCGACAGTGGAAAGAAAAAGAACATAGTTTTCCGCAAAATCAATGAATGGCTGAACTTGGGCAATCACAAATACGTGGCTGTCATTAACCGGGTCATCAGGAATCCCCGCCGCTTGATGAGTGCGTTCGGCCTGGTACTGGTTGCCATTTTCATTATCCACCGGTTGGTGCCTACCAGCTTCCTGCCGGTAGAAGACCAGGGCTATTTTAAGATAGAGTTGGAGTTGCCGGAAGGTGCTACTTTGGAGCGAACCCGTGTGGTGACCGACCGTGCCGTGCAATACTTGGAGAAGAATCCCTATGTGGCCTATGTGCAGAACGTGACGGGTAGCAGCCCCCGTGTGGGTAGCAACCAGGCACGCAGTGAGCTGACGGTTATTCTGAAACCGTGGGAAGAGCGTAAGGGGATTTCCATCGATAAGATAATGGAGAATGTGGAGAAGGATTTGAAGGAATATCCCGAATGCAAGGTCTATCTTTCCACGCCTCCGGTCATTCCGGGATTGGGTACCTCGGGAGGTTTCGAAATGCAGCTTGAGGCGCGTGGAGAGGCGACGTTTGACAACTTGGTGCAGGCGGCAGATACGCTGATGTATTATGCCCAGAAGCATAAGGAGCTGACGGGGCTTTCATCATCCTTGCAGTCTGAAATACCGCAACTTTATTTTGATGTGGACCGTGATAAGGTGAAAATGCTGGGTGTGCCCCTGGCGGATGTATTCTCTACCATGAAGGCCTATACCGGTTCAGTATATGTGAATGACTTCAATATGTTCAACCGTATATATAAGGTGTATATCCAGGCCGAGGCTCCTTATCGTGAGCATAAGGACAATATCAACTTGTTCTTTGTAAAGGCAAAGGACGGAGTGATGGTGCCGCTTACTTCCTTGGGAAATGCCTCTTATACCACCGGTCCGGGCAGTATCAAGCGTTTCAATATGTTTACCACTGCCGTCATCCGCGGTTCTGCGGCACAAGGCTACAGTTCCGGCCAGGCAATGGAGATTATGGAGCAGATTGCACGTAACCACTTGCCGGACAATATCGGTCTGGAGTGGAGTGGCCTTTCCTATCAGGAAAAGAAGGCGGGAGGACAGACGGGTCTTGTGCTTACGCTGGTATTCCTTTTCGTATTCCTCTTTTTGGCTGCGCAATATGAAAGTTGGACGGTGCCTATCGCTGTATTGCTTTCACTGCCGGTTGCCGCTTTGGGTGCCTATCTGGGCGTTGTGATATGCGGATTGGAGAATGATATTTATTTCCAGATCGGCTTGGTGATGCTGGTGGGGCTTGCGGCAAAGAATGCCATTTTGATTGTGGAGTTTGCCAAGGTGCAGGTTGACAAGGGAGGAGACTTGATACAGTCTGCCATCCATGCTGCCCAACTCCGTTTCCGGCCTATCCTGATGACTTCCCTCGCCTTTGTATTGGGAATGCTTCCTATGGTGTTGGCAAGCGGACCGGGCTCGGCGAGCCGTCAGGCCATCGGTACGGGTGTTTTCTTCGGAATGATATTTGCCATTGTATTCGGTATTGTGCTTGTACCGTTCTTCTTTGTCCTGGTATACAAGACAAAAGCCAAAGTGCAGCATAAGATTAAGAAAGACTGA	MKVSFFIDRPVFSAVISIVIVIVGIIGLTMLPVDQYPQITPPVVKISASYPGASALTVSQAVATPIEQEINGTPGMLYMESNSSNSGGFSATVTFDVSADPDLAAVEIQNRVKLAESRLPAEVIQNGISVEKQAPSQLMTICLTSSDPKFDEIYLSNFATINVLDLLRRIPGVGRVSNIGSRYYAMQIWALPDKLANFGLTVQDLQNALKDQNRESAAGVLGQQPVKGLDITIPITTQGRLSSAKQFEDIVVRANANGSIIRLRDVARVSLEASSYSTESGINGENAAVLGIYMLPGANAMEVAKSVKAAMEEISANFPEGMSYEIPFDMTTYISESIHEVYKTLFEALILVVLVVFLSLQSWRATVIPIVAVPISLIGTFGFMLIFGFSLNILTLLGLILAIGIVVDDAIVVVENVEHLMETEKLSPYEATKRAMNGLASALIATSLVLCAVFVPVSFLSGITGQLYRQFTITIAVSVLLSTVVALTLSPVMCSLILKPDSGKKKNIVFRKINEWLNLGNHKYVAVINRVIRNPRRLMSAFGLVLVAIFIIHRLVPTSFLPVEDQGYFKIELELPEGATLERTRVVTDRAVQYLEKNPYVAYVQNVTGSSPRVGSNQARSELTVILKPWEERKGISIDKIMENVEKDLKEYPECKVYLSTPPVIPGLGTSGGFEMQLEARGEATFDNLVQAADTLMYYAQKHKELTGLSSSLQSEIPQLYFDVDRDKVKMLGVPLADVFSTMKAYTGSVYVNDFNMFNRIYKVYIQAEAPYREHKDNINLFFVKAKDGVMVPLTSLGNASYTTGPGSIKRFNMFTTAVIRGSAAQGYSSGQAMEIMEQIARNHLPDNIGLEWSGLSYQEKKAGGQTGLVLTLVFLFVFLFLAAQYESWTVPIAVLLSLPVAALGAYLGVVICGLENDIYFQIGLVMLVGLAAKNAILIVEFAKVQVDKGGDLIQSAIHAAQLRFRPILMTSLAFVLGMLPMVLASGPGSASRQAIGTGVFFGMIFAIVFGIVLVPFFFVLVYKTKAKVQHKIKKD	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	97.83	gnl|BL_ORD_ID|137|hsp_num:0	153		
k141_41758_39 # 56096 # 56209 # 1 # ID=67_39;partial=00;start_type=ATG;rbs_motif=AAAA;rbs_spacer=12bp;gc_cont=0.404	k141_41758_39 	56096	56209	+	Strict	500	22.3274	AAC(3)-IIIb	100.0	3002537	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGATGAGGGTGTGCCGAATGTCTGACGGAATGATAGCTGAAAAACGTTTTGGCACACCCTCTCTCTTTTACGATAAATCACTGTTCGAAAACCCTATTTACCATGAAACTTAA	MMRVCRMSDGMIAEKRFGTPSLFYDKSLFENPIYHET	MTPASFVTRASLAADLASLGLAPGDAVMVHAAVSKVGRLLDGPDTIISALSDAVGPEGTVLAYADWEARYEELADEHGRVPVQWRDHIPPFDPQRSRAIRDNGVLPEFLRTTPGALRSGNPGASVVALGAKAEWFTADHPLDYGYGEGSPLAKLVAAGGRVLMLGAPLDTLTLLHHAEHLADIPGKRIKRIEVPFATPTGTQWRMIEEFDTGDPIVAGLAEDYFAGIVTEFLASGQGRQGLIGAAPSVLVDAAAITAFGVTWLEKRFGTPSP	13.60	gnl|BL_ORD_ID|381|hsp_num:0	410	True	loose hit with at least 95 percent identity pushed strict
